CVX
stock NYSEKey stats
- Open
- $193.79
- +1.29%
- Close
- $191.01
- -0.17%
- Current
- $191.01
- Prev close
- $191.33
- Today
- 9.05M
- 3-mo avg
- 12.10M
Fundamentals
Each ratio reads FY2025 figures against the latest price, graded so the quality shows at a glance.
At 29x, investors are paying up; a fair amount of future growth is already in the price.
Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.
A 3.6% yield is a healthy, generally sustainable level of cash income.
The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.
A 6.7% margin is solid, in the ordinary range for a profitable company.
The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.
A 6.6% return on equity is respectable, in the normal range.
Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.
A 3.8% return on assets is reasonable for a company of this kind.
Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.
At 0.71, the company carries less in liabilities than in equity, a conservative balance sheet.
Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.
At 1.15, short-term assets cover short-term bills with a little room to spare.
Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.
Revenue fell 4.6% from the prior year; the top line is contracting.
Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.
Net income fell 30.4% from the prior year; profit is shrinking.
Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.
Financials
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Revenue | $155.6B | $235.7B | $196.9B | $193.4B | $184.4B |
| Net income | $15.6B | $35.5B | $21.4B | $17.7B | $12.3B |
| Diluted EPS | $8.14 | $18.28 | $11.36 | $9.72 | $6.63 |
| Dividend / share | $5.31 | $5.68 | $6.04 | $6.52 | $6.84 |
| Total assets | $239.5B | $257.7B | $261.6B | $256.9B | $324.0B |
| Total liabilities | $99.6B | $97.5B | $99.7B | $103.8B | $131.8B |
| Shareholder equity | $139.9B | $160.2B | $161.9B | $152.3B | $186.4B |
| Q3-2023 | Q1-2024 | Q2-2024 | Q3-2024 | Q1-2025 | Q2-2025 | Q3-2025 | Q1-2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $51.9B | $46.6B | $49.6B | $48.9B | $46.1B | $44.4B | $48.2B | $47.6B |
| Net income | $6.5B | $5.5B | $4.4B | $4.5B | $3.5B | $2.5B | $3.5B | $2.2B |
| Diluted EPS | $3.48 | $2.97 | $2.43 | $2.48 | $2.00 | $1.45 | $1.82 | $1.11 |
| Dividend / share | $1.51 | $1.63 | $1.63 | $1.63 | $1.71 | $1.71 | $1.71 | $1.78 |
Recent SEC filings
- 10-Q Quarterly report
- 8-K Current report
- 8-K Current report
- DEF 14A Proxy statement
- 8-K Current report
- 10-K Annual report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K/A Current report (amended)
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report